| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000015607 |
| Receipt No. | R000017821 |
| Official scientific title of the study | Diagnosis of Alzheimer disease using 11C-PIB PET |
| Date of disclosure of the study information | 2014/11/10 |
| Last modified on | 2016/05/31 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Diagnosis of Alzheimer disease using 11C-PIB PET | |
| Title of the study (Brief title) | Diagnosis of Alzheimer disease using 11C-PIB PET | |
| Region |
|
|
| Condition | |||
| Condition | Alzheimer's disease | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the usefulness of 11C-PIB PET in the differential diagnosis of Alzheimer's type dementia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | relationship between 11C-PIB PET avidity and change of cognitive function. |
| Key secondary outcomes | relationship between 11C-PIB PETpattern and change of cognitive function. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | injection of PET tracer | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Mild dementia is suspected and is not typical AD
2) include atypical young patients 3) Regardless of sex 4) informed consent is available |
|||
| Key exclusion criteria | 1) typical AD
2) can not keep at rest during scan 3) bad general condition 4) receiving anti-amyloid antibody therapy 5) can not sign in the IC or can not understand the IC 6) Those who is thought to be inappropriate by researcher |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Honda |
| Organization | Kyushu University Hospital |
| Division name | Department of clinical radiology |
| Address | 3-1-1 Maidashi |
| TEL | 092-642-5695 |
| honda@radiol.med.kyushu-u.ac.jp | |
| Public contact | |
| Name of contact person | Shingo Baba |
| Organization | Kyushu University |
| Division name | Clinical Radiology |
| Address | 3-1-1 Maidashi |
| TEL | 092-642-5695 |
| Homepage URL | |
| sbaba127@radiol.med.kyushu-u.ac.jp | |
| Sponsor | |
| Institute | kyushu university hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Grant-in-Aid for Scientific Research |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017821 |